Understanding how RNA editing affects TDP-43 movement in cells

Mechanisms of A-I RNA editing-mediated nuclear export of TDP-43

NIH-funded research St. Joseph's Hospital and Medical Center · NIH-10575984

This study is looking at how changes in RNA editing affect the movement of a protein called TDP-43, which is connected to diseases like ALS and Alzheimer's, to help find new ways to treat these conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSt. Joseph's Hospital and Medical Center NIH-funded
Lab location1 site (Phoenix, United States)
Project IDNIH-10575984 on NIH RePORTER

What this research studies

This research investigates the role of RNA editing in the movement of TDP-43, a protein linked to neurodegenerative diseases like ALS and Alzheimer's. The study focuses on how changes in RNA editing can influence TDP-43's location within cells, particularly its export from the nucleus to the cytoplasm. By examining these mechanisms, the research aims to uncover potential therapeutic targets that could mitigate the harmful effects of TDP-43 aggregation. Patients may benefit from insights gained into the molecular processes underlying their conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with ALS, frontotemporal dementia, or Alzheimer's disease.

Not a fit: Patients with neurodegenerative diseases not associated with TDP-43 pathology may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases associated with TDP-43.

How similar studies have performed: While the specific approach of targeting RNA editing in TDP-43 pathology is novel, related research has shown promise in understanding TDP-43's role in neurodegenerative diseases.

Where this research is happening

Phoenix, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.